filings.toolsItem 1A. RISK FACTORS
2K characters. Original on sec.gov · Markdown
Item 1A. RISK FACTORS
There have been no material changes in our risk factors from those disclosed under Item 1A “Risk Factors” included in our Annual Report on Form 10-K for the fiscal twelve months ended December 31, 2023 filed on March 1, 2024 with the SEC.
Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
There were no sales of equity securities by the Company during the fiscal six months ended June 30, 2024.
Purchases of Equity Securities by the Issuer and Affiliated Purchasers
During the fiscal three months ended October 1, 2023, our Board authorized a share repurchase program, under which we are authorized to repurchase up to 27,000,000 shares of our outstanding common stock in open market or privately negotiated transactions. The program has no expiration date and may be suspended or discontinued at any time. The intent of this repurchase program is to offset dilution from the vesting or exercise of equity awards under the Kenvue 2023 Plan (as defined in Note 8, “Stock-Based Compensation,” to the Condensed Consolidated Financial Statements included herein).
The following table represents our purchases of common stock during the fiscal three months ended June 30, 2024:
| (Shares in Thousands) | ||||||||||||||||||||||||||
| Period | Total Number of Shares Purchased | Average Price Paid Per Common Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | Approximate Maximum Number of Shares That May Yet Be Purchased Under the Plans or Programs | ||||||||||||||||||||||
| April 1, 2024 - April 30, 2024 | — | $ | — | — | 22,050 | |||||||||||||||||||||
| May 1, 2024 - May 31, 2024 | — | $ | — | — | 22,050 | |||||||||||||||||||||
| June 1, 2024 - June 30, 2024 | — | $ | — | — | 22,050 | |||||||||||||||||||||
| Total number of shares purchased | — |
Previous: Item 4. CONTROLS AND PROCEDURES · Next: Item 5. OTHER INFORMATION